Antihypertensive Cardio Labeling Should Be Applied To New Classes – Cmte.

Class labeling for reduction of cardiovascular outcomes based on blood pressure lowering should be applied to new classes of antihypertensives, members of FDA's Cardiovascular & Renal Drugs Advisory Committee said